Shareholders' equity · 2011–2025
Halozyme Therapeutics shareholders' equity
$48.8M−86.6% · FY2025
Halozyme Therapeutics (HALO) reported $48.8M in shareholders' equity for fiscal 2025, −86.6% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $48.8M | −86.6% | Open → |
| FY20242024-12-31 | $364M | +334.1% | Open → |
| FY20232023-12-31 | $83.8M | −50.6% | Open → |
| FY20222022-12-31 | $170M | −13.8% | Open → |
| FY20212021-12-31 | $197M | +30.4% | Open → |
| FY20202020-12-31 | $151M | +64.6% | Open → |
| FY20192019-12-31 | $91.8M | −63.1% | Open → |
| FY20182018-12-31 | $249M | +19.4% | Open → |
| FY20172017-12-31 | $208M | +$241M | Open → |
| FY20162016-12-31 | −$32.5M | −$75.5M | Open → |
| FY20152015-12-31 | $43.0M | +4.0% | Open → |
| FY20142014-12-31 | $41.4M | +$61.3M | Open → |
| FY20132013-12-31 | −$20.0M | −$68.8M | Open → |
| FY20122012-12-31 | $48.9M | +348.2% | Open → |
| FY20112011-12-31 | $10.9M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +11.3%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Halozyme Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/halozyme-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Halozyme Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/halozyme-therapeutics/shareholders-equityBibTeX
@misc{companiesranked-en-company-halozyme-therapeutics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Halozyme Therapeutics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/halozyme-therapeutics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001159036-26-000104 · August 6, 2026
{{cite web |title=Halozyme Therapeutics shareholders' equity — 10-Q (0001159036-26-000104) |url=https://www.sec.gov/Archives/edgar/data/1159036/000115903626000104/halo-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.